Johanna Mercier plans sale of 3,000 shares

Johanna Mercier has filed a Form 144 notice to sell 3,000 shares of common stock through Morgan Stanley Smith Barney on or about 01/15/2026 on the NASDAQ market.

Accepted by SEC EDGAR 01/15/2026 - 04:02 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Johanna Mercier has filed a Form 144 notice to sell 3,000 shares of common stock through Morgan Stanley Smith Barney on or about 01/15/2026 on the NASDAQ market. The planned sale has an aggregate market value of $372,930.00, and the issuer has 1,240,679,623 shares outstanding. The shares to be sold come from restricted stock and performance share awards acquired from the issuer in early 2024.

Over the past three months, Johanna Mercier has already sold 3,000 and 28,000 shares of common stock in separate transactions, with gross proceeds of $366,000.00 and $3,524,173.10, respectively. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing for GILD disclose?

This Form 144 discloses that Johanna Mercier intends to sell 3,000 shares of common stock with an aggregate market value of $372,930.00 through Morgan Stanley Smith Barney on or about 01/15/2026 on the NASDAQ.

How many GILD shares has Johanna Mercier sold recently?

In the last three months, Johanna Mercier has sold 3,000 shares of common stock on 12/15/2025 for gross proceeds of $366,000.00 and 28,000 shares on 11/17/2025 for gross proceeds of $3,524,173.10.

What is the source of the GILD shares Johanna Mercier plans to sell?

The planned 3,000-share sale relates to awards acquired from the issuer in 2024, including 1,859 shares from restricted stock granted on 03/10/2024 and 1,141 shares from performance shares granted on 01/31/2024.

How many GILD shares are outstanding according to this filing?

The filing states that the number of common shares outstanding is 1,240,679,623.

Which broker is handling the planned GILD share sale?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker for the planned 3,000-share sale on NASDAQ.

What representation does the seller make about inside information in this GILD Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001782135
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GILEAD SCIENCES, INC.
SEC File Number	000-19731
Address of Issuer	333 Lakeside Drive Foster City CALIFORNIA 94404
Phone	(650) 574-3000
Name of Person for Whose Account the Securities are To Be Sold	JOHANNA MERCIER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	372930.00	1240679623	01/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/10/2024	Restricted Stock	ISSUER			1859	03/10/2024	Not Applicable
Common	01/31/2024	Performance Shares	ISSUER			1141	01/31/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	12/15/2025	3000	366000.00
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	11/17/2025	28000	3524173.10

144: Remarks and Signature

Remarks
Date of Notice	01/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Johanna Mercier
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)